Browse All

Current Filters

CLEAR FILTER x

TITLE

Balancing Ethics and Efficacy: Examining the Scope of Artificial Intelligence in Neurocognitive Rehabilitation

Author:Morris, Kevin   Parmar, Japjee   Torres, Alia   Tsouli Kamal, Taha   

Session Name:P4: Neuro-rehabilitation: Devices and Technology  

Topic:Neuro-rehabilitation  

Program Number:P4.004  

Author Institution:Department of Research and Development, Aklun Biotech LLC Nagpur  Department of Innovation, Morris Lifesciences, Center for Innovation and Research, Nagpur, India  Department of Internal Medicine, Maharashtra university of health sciences, Nashik, India, Nagpur, India  Université Mohammed VI des Sciences et de la Santé, Casablanca, Morocco, Casablanca, Morocco  

Balancing Growth and Performance: Student Experiences with Hidden Curriculum and Psychological Safety in a Neurology Clerkship

Author:Macalino, Ashlee Joan   Pescatello, Meredith   Thompson-Stone, Robert   Mooney, Christopher   

Session Name:P7: Education, Research, and Methodology: Medical Student Education in Neurology 1  

Topic:Education, Research, and Methodology  

Program Number:P7.002  

Author Institution:University of Rochester, Rochester, NY  

Barriers and Solutions for Initiating Monoclonal Antibody Therapy in Alzheimer’s Disease

Author:Gelblum, Jeffrey   Yoest, Katie   Weisman, David   

Session Name:P12: Aging, Dementia, and Behavioral Neurology: Alzheimer's Treatment  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P12.006  

Author Institution:First Choice Neurology, Aventura, FL  MedThink SciCom, Raleigh, NC  Abington Neurological Associates, Clinical Research Center, Abington, PA  

Barrow Global Neurology: A Bidirectional Global Neurology Residency Training Program

Author:Bowlsby, Alyssa   Sleem, Tamara   Racette, Brad   Mubarak, Huiam   

Session Name:P6: Global Health: Education and Capacity Building  

Topic:Global Health and Neuroepidemiology  

Program Number:P6.001  

Author Institution:Barrow Neurological Institute, Phoenix, AZ  

Baseline Characteristics for INFRONT-3: A Phase 3 Double-Blind, Placebo-Controlled 96-Week Study Evaluating Latozinemab in FTD-GRN

Author:Carter, Lawrence   Borroni, Barbara   Mummery, Catherine   Le Ber, Isabelle   Boeve, Bradley   Boxer, Adam   Smithey, Megan   Chow, Tiffany   Huang, Julie   Guizzetti, Leonardo   Salvadore, Giacomo   Romano, Gary   

Session Name:P8: Aging, Dementia, and Behavioral Neurology: Non-AD Treatments  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P8.005  

Author Institution:Alector, South San Francisco, CA